Agenda and minutes for the 95th ACAF meeting

Agenda

1. Minutes from the 94th ACAF meeting – Members will review the minutes from the last meeting and provide comments on any changes needed. ACAF/95/01
2. Dossier for assessment: RP1904 Biomin C5 - Members will discuss the application dossier and carry out a risk assessment on the efficacy section. ACAF/95/02
3. Dossier for assessment: RP2071 Enterosure conc – Members will discuss the application dossier and carry out a full risk assessment of the additive. ACAF/95/03
4. Dossier for assessment: RP2107 Availa CR – Members will discuss the application dossier and carry out a full risk assessment of the additive. ACAF/95/04
5. Response to RFI: RP1275 Quantum Blue – Members will revisit the applicant’s response to the Committee’s request. ACAF/95/05
6. Response to RFI: RP1696 Bacillus velezensis ATCC PTA-6737 – Members will revisit the applicant’s response to the Committee’s request. ACAF/95/06
7. Response to RFI: RP1888 Lactiferm – Members will revisit the applicant’s response to the Committee’s request. ACAF/95/07
8. Internal Safety Assessment: RP1499 Balancius muramidase – Members will review and provide feedback on an internal Safety Assessment prepared by the Secretariat. ACAF/95/08
9. Draft assessment –– RP1070/1071/1072, RP1243, RP1258, RP1317, RP1366, RP1393, RP1400 and RP1512 Members will evaluate the draft assessments and provide feedback on the content of the document. Members will also finalise previous opinions presented to the Committee. ACAF/95/09
10. Qualified Presumption of Safety (QPS) Committee Paper – Members will discuss continuing to use the QPS approach as part of the risk assessment process. ACAF/95/10
11. Any other business: upcoming applications. ACAF/95/AOB

Minutes 

Minutes of the 95th ACAF meeting held on Wednesday 18th December 2024